15. El-Omar E., Penman I., Ardill J.E. et al. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. - Gut. -
1995. - Vol.36. -P-534-538.
16. Feinle-Bisset C, Vozzo R., Horowitz M., Talley N.J. Diet, food intake and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia //
Amer.J.Gastroenterol. - 2003. - Vol.99. P.170-181.
17. Ford F.C. Ching E., Moayyedi P. Meta-analysis of diagnostic tests for coeliac disease in dyspepsia // Aliment. Pharmacol. Ther. - 2009. - Vol. 30. - P.28-36.
18. Fiihrer M., Vogelsang M., Hammer J. A double blind, placebo controlled study of the oral capsaicin test in patients with functional dyspepsia // Gut. - 2008. - Vol.57. - Suppl.
II. - P.A.38.
19. Holtmann G. Understanding functional dyspepsia & its treatment with itopride // Medical
Tribune. - 2006. - 1-15 Nov.
20. Holtmann G., Talley N.J. Clinician's manual on managing dyspepsia. - Life Science
Communications. - London, 2000. - 88 p.
21. Holtmann G., Talley N.J., T.Liebregts et al. A placebo-controlled trial of itopride in functional dyspepsia // N.Engl. J. Med. -2006. - Vol.354. - P- 832-840.
22. Holtmann G., Talley N.J. Hypothesis driven research and molecular mechanisms in functional dyspepsia: the beginning of a beautiful cooperation in research and practice? //
Amer.J.Gastroenterol. - 2006. - Vol.101. - P.593-595.
23. Jackson J.L., O'Malley P.G., Tomkins G. et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis // Amer.J.Med. - 2000. -
Vol.108. - P.65-72.
24. Jones M.P., Ebert Ch.C. Bloating and somatosensory amplification in functional dyspepsia (FD) // Amer.J.Gastroenterol. - 2003. - Vol.98. - P.63-64.
25. Kadota K., Takeshima F., Yoda A. et al. Effect of smoking cessation on gastric emptying in smokers // Gut. - 2008. - Vol.57. - Suppl. II. - P.A2.
26. Kanath S. Comparative evaluation of the efficacy and tolerability of itopride and metaclopramide in patients with non-ulcer dyspepsia // JAMA-India. - 2003. - Vol.2. -
P.95-98.
27. Keohane J., Quigley E.M.M. Functional dyspepsia: The role of visceral hypersensitivity in its pathogenesis // World J.Gastoenterol. - 2006. - Vol.12. - P.2672-2676.
28. Knill-Jones R.P. Geographical differences in the prevalence of dyspepsia // Scand.
J.Gastroenterol. - 1991 - Vol. 26. - Suppl.182. - P.-17-24.
29. Koloski N.A., Talley N.J., Boyce Ph.M. Epidemiology and health care seeking in the functional GI disorders: a population-based study // Amer.J.Gastroenterol.- 2002.-Vol.97.
_ P.2290-2299.
30. Lapidus L., Andersson S., Bengtsson G., Kilander A. Prognosis of dyspepsia in women - a 24-year follow-up of a population sample // Gut. -2002. - Vol.34. - Suppl.II. - P.A106.
31. Lin Z., Eaker E.Y., Sarosiek I., McCallum R. Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia // Amer.J.Gastoenterol. - 1999. - Vol.94. _
R2384-2389.
32. Locke G.R., Weaver A.L., Melton L.J., Talley N.J. Phsychological factors are linked to functional gastrointestinal disorders: a population based nasted case-control study. -
Amer.J.Gastroenterol. -2004. - Vol.99. - P-350-357-
33. McQuaid K.R. Dyspepsia // Sleisenger and Fordtran's gastrointestinal and liver disease
(Ed.: M.Feldmanetal.),7thed. - Philadelphia-London-Toronto-Montreal-Sydney-Tokyo,
2002. - P.102-118.
34. Moayyedi P., Soo S., Deeks J. et al. Systemic review: Antacids, H2-receptor antagonists, prokinetiks, bismuth and sucralfate therapy for non-ulcer dyspepsia // Aliment,
Pharmacol.Ther. - 2003. - Vol 17. - P.1215-1227.
35. Moayyedi P., Deeks J., Talley N.J. et al. An update of the Cochrane systematic review of
Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepance between systematic reviews //Amer. J. Gastroenterol. - 2003. -Vol.98. - P.2621-2626.
36. Moayyedi P., Delaney B.C., Vakil N. The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis // Gastroenterology. - 2004. -
Vol.127. R1329-1337.
37. Monkemiiller K., Malfertheiner P. Drug treatment of functional dyspepsia // World
J.Gastroenterol. - 2006. - V0I12. - P.2694-2700.
38. Muller-Lissner S., Koelz H.R Dyspepsiefibel. - Berlin-Heidelberg-New York. - 1991. -
67 S.
39. Nimmuan C, Rabe-Hesketh S., Wessely S., Hotopf M. How many functional somatic syndromes? // J.Phychosom.Res. - 2001.-Vol.51. - P.549-557.
40. Nyren ОС // Maastricht-3
Guidelines for Helicobacter pylori infection. - 13. United European Gastroenterology
Week. - Copenhagen. - 2005 (oral presentation).
42. Peura D. Meeting expectations in FD: clinical and regulatory objectives. Clinician's viewpoint // Functional dyspepsia: current evidence and cutting edge outcomes . -
Abstract book. - Montreal, 2005. - P.16-18 43. Samson M., Verhagen M.A., van Berge-Henegouwen G.P. et al. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. - Gastroenterology. - 1999. -Vol.116. - P.515-520.
44. Sarnelli G., Caenepeel Ph., Geypens B. et al. Symptoms associated with impared gastric emptying of solids and liquids in functional dyspepsia // Amer.J.Gastroenterol. - 2003. -
Vol.98. - P.783-788.
45. Sarnelli G., De Giorgi F., Atteo E. et al. Frequency, symptom evolution and pathophysiological correlates in prospectively identified patients with postinfectious dyspepsia // DDW - New Orleans, 2010. - Abstract M2010.
46. Sawant P., Das H.S., DesaiNetal. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia // JAPI. -
2004 - Vol.52. - P.626-628.
47. Soo Sh., Forman D., Delaney C, Moayyedi P. A systemic review of psychological therapies for nonulcer duspepsia // Amer. J.Gastroenterol. - 2004. - Vol.99. _ P.1817-
1822.
48. StanghelliniV, TosettiC, PaternicoA etal. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia // Gastroenterology. - 1996. - Vol.110. -
P.1036-1042.
49. Tack J. New therapeutic targets for FD: what, how and whom? // Functional dyspepsia: current evidence and cutting edge outcomes . - Abstract book. - Montreal, 2005. - P.22-
24.
50. Tack J., Talley N.J., Camilleri M. et al. Functional gastroduodenal disorders //
Gastroenterology. -2006. -Vol.130. - P. 1466-1479.
51. Tack J. Piessevaux H., Coulie В et al. Role of impaired gastric accommodation to a meal in functional dyspepsia // Gastroenterology. - 1998. - Vol.115. _ R1346-1352.
52. Tack J., Caenepeel P., Fischler B. et al. Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia // Gastroenterology. - 2001. - Vol.121. - P.526-
535 53. Talley N.J. and the working team forfunctional gastroduodenal disorders. Functional gastroduodenal disorders // In: The functional gastrointestinal disorders. - Boston - New
York-Toronto-London, 1994. - P.71-113.
54. Talley N.J., Helgeson S.L., Zinsmeister A.R. et al. Gastrointestinal tract symptoms and self-reported abuse: a population-based-study // Gastroenterology. - 1994 .-Vol.107.
P.1040-1049.
55. Talley N.J., Janssens L., Lauritsen K. et al. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 month follow up // Br.Med.J. -1999. - Vol.318. - P.833-837.
56. Talley N.J., Meineche-Schmidt V, Pare P. et al. Eficacy of omeprazole im functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies) //Aliment. Pharnacol. Ther.-l998.-Vol.l2.-P.l055-lo65.
57. Talley N.J., Stanghellini V, Heading R.C. et al. Functional gastroduodenal disorders //
Rome II. The Functional Gastrointestinal Disorders (Ed D.A.Drossman).- 2. Edition. -
Allen Press. - 2000. -P.299-350.
58. Tominaga K., Suzuki H., Umegaki E. et al. Rabeprazole improves the symptoms of functional dyspepsia - a double-blind randomized placebo-controlled multi-center trial in
Japan: The CAESAR study // DDW - New Orleans, 2010. - Abstract 383.
59. Van Lelyveld N., Scheffer R,., Mundt M., Samson M. Partial gastric volumes and upper abdominal sensations in functional dyspeptic and GERD patients: a 3D ultrasonographic study // Amer.J.Gastroenterol. - 2006. -Vol.101. - P.1845-1852.
60. Warrwewijk C.J., Van Oijen M.G.H., Paloheimo L.I. et al. Influence of gastric mucosal status on successs of stepwise acid suppressive therapy for dyspepsia //
Aliment.Pharmacol.Ther. - 2009. -Vol.30. - P.82-89.
61. Wilhelmsen I., Haug Т, Sipponen P., Berstad A. Helicobacter pylori in functional dyspepsia // Scand.J.Gastroenterol. - 1994. - Vol.29. - P-522-527.
|
Скачать 273.6 Kb.